Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older

Lancet Healthy Longev. 2021 Sep;2(9):e529-e530. doi: 10.1016/S2666-7568(21)00205-1. Epub 2021 Aug 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • ChAdOx1 nCoV-19
  • Humans
  • Vaccination
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines
  • ChAdOx1 nCoV-19
  • BNT162 Vaccine